Compare CHEF & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHEF | TWST |
|---|---|---|
| Founded | 1985 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | 2011 | 2018 |
| Metric | CHEF | TWST |
|---|---|---|
| Price | $85.14 | $68.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $76.33 | $46.88 |
| AVG Volume (30 Days) | 349.8K | ★ 1.5M |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.27 | ★ 63.89 |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $1,301,520,000.00 | $376,572,000.00 |
| Revenue This Year | $8.66 | $18.91 |
| Revenue Next Year | $7.83 | $15.07 |
| P/E Ratio | $206.73 | ★ N/A |
| Revenue Growth | 9.11 | ★ 20.32 |
| 52 Week Low | $53.24 | $23.30 |
| 52 Week High | $83.35 | $80.50 |
| Indicator | CHEF | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 75.26 | 59.20 |
| Support Level | $57.47 | $41.85 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.66 | 5.06 |
| MACD | 0.30 | 0.37 |
| Stochastic Oscillator | 99.82 | 57.25 |
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States, the Middle East and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.